Breitner, John C <br/><br/>
Extended results of the Alzheimer's disease anti-inflammatory prevention trial.  [electronic resource] 

 -  Alzheimer's & dementia : the journal of the Alzheimer's Association  Jul 2011 
 - 402-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1552-5279 
<br/><br/><label>Standard No.: </label>10.1016/j.jalz.2010.12.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Celecoxib<br/>Confidence Intervals<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Naproxen--therapeutic use<br/>Neuropsychological Tests<br/>Peptide Fragments--cerebrospinal fluid<br/>Proportional Hazards Models<br/>Psychiatric Status Rating Scales<br/>Pyrazoles--therapeutic use<br/>Sulfonamides--therapeutic use<br/>tau Proteins--cerebrospinal fluid